The deal broadens Ingredion’s portfolio in texturants, sugar reduction, and fortification while adding capabilities in multi-ingredient systems and recipe development. It also expands the company’s reach across a wider range of food and beverage applications.Tate & Lyle shareholders will receive 595 pence per share, a roughly 59% premium to the May 13, 2026, closing price, plus certain dividends.Synergies, Financing, and Deal TimelineIngredion expects the transaction to generate about $130 million in annual cost synergies by 2030 and to be accretive to adjusted EPS in the first full year after closing. One-time integration costs are projected at about $175 million.The deal, which has unanimous board backing from both companies, is expected to close in the second half of 2027, subject to shareholder and regulatory approvals.Ingredion plans to fund the acquisition through existing cash, new debt, and a committed bridge financing facility. The company expects leverage to decline to about 2.5 times net debt-to-adjusted EBITDA within 18 months after closing.Ingredion said it has secured an irrevocable undertaking from Huber Equity Corporation to support the transaction, covering about 16.8% of Tate & Lyle’s outstanding shares.As of March 31, 2026, Ingredion had total debt of $1.8 billion and cash, including short-term investments, of $918 million.INGR Technical Outlook: Trend, Moving Averages, and MomentumINGR stock is trading lower in premarket Monday and is still in a defined longer-term downtrend: the stock is trading 3.6% below its 20-day SMA, 8.7% below its 50-day SMA, and 13.3% below its 200-day SMA. That distance from the major averages helps explain why rebounds have struggled to turn into sustained uptrends.The moving-average structure stays bearish, with the 20-day SMA below the 50-day SMA and a death cross (50-day SMA below the 200-day SMA) still in place after forming in August 2025. From a “trend first” perspective, bulls typically want to see price start reclaiming the 20-day/50-day zone before trusting that the path of least resistance has flipped higher.For momentum, MACD is the more useful lens right now because it speaks to whether downside pressure is easing even while the trend remains weak. MACD is above its signal line, and the histogram is positive, which points to improving momentum versus the prior downswing—but it hasn’t yet translated into a clean trend reversal on the moving averages.The stock is also pressing the bottom of its 52-week range, with the 52-week low at $98.29 and shares hovering near that area premarket. That makes the next few dollars especially important: a firm hold can spark a bounce attempt, while a breakdown can invite another leg lower as stops get triggered.